Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy.
about
Molecular Mechanisms and Therapeutic Effects of (-)-Epicatechin and Other Polyphenols in Cancer, Inflammation, Diabetes, and NeurodegenerationMitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in miceBaicalein, a Bioflavonoid, Prevents Cisplatin-Induced Acute Kidney Injury by Up-Regulating Antioxidant Defenses and Down-Regulating the MAPKs and NF-κB PathwaysDaily Intake of Grape Powder Prevents the Progression of Kidney Disease in Obese Type 2 Diabetic ZSF1 RatsTempol, a superoxide dismutase mimetic agent, ameliorates cisplatin-induced nephrotoxicity through alleviation of mitochondrial dysfunction in miceMitochondrial dysregulation and protection in cisplatin nephrotoxicity.5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in vitro and in vivo.Mitochondrial function and disturbances in the septic kidneyRecovery of Indicators of Mitochondrial Biogenesis, Oxidative Stress, and Aging With (-)-Epicatechin in Senile Mice.Increasing cGMP-dependent protein kinase I activity attenuates cisplatin-induced kidney injury through protection of mitochondria functionSignalling mechanisms involved in renal pathological changes during cisplatin-induced nephropathy.(-)-Epicatechin regulates blood lipids and attenuates hepatic steatosis in rats fed high-fat diet.Direct effects of (-)-epicatechin and procyanidin B2 on the respiration of rat heart mitochondria.Amelioration of cisplatin-induced nephrotoxicity in rats by triterpenoid saponin of Terminalia arjuna.(-)-Epicatechin stimulates mitochondrial biogenesis and cell growth in C2C12 myotubes via the G-protein coupled estrogen receptor.Toxicological Implications of Mitochondrial Localization of CYP2E1.Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.Flavonoids in Kidney Health and Disease.
P2860
Q26800963-63078F31-A360-4B47-93A7-28F65638A4AFQ28546437-5EE4B986-7F50-41FC-900B-FD2317DED557Q28546838-92C488C0-621A-44ED-8468-8A1CDCEA2644Q33616669-3DB64140-24DD-4C4C-A54F-155A07CA75F2Q34278299-613B83F8-5358-4007-A61E-5DE80BEFA26FQ34762287-45E351DC-DF17-4FF2-85F9-A9907D77A171Q35063808-262AE8F3-651E-4E04-8727-269FDCB82C56Q35736542-3CDBA44A-5F30-4208-B93F-A1229740AD71Q36468847-9B77E7FC-8C52-4A35-8174-F43DC65B9DF7Q37142629-C60E7955-395D-4023-8C23-DC40A233D4F3Q38127618-F8B19516-ADE8-4851-B674-51BA5A12FC39Q38666966-25AB66E6-BF07-4643-A6F7-2D6BBCC22C81Q41157091-FBAD175D-50AD-44C4-AD14-998F1A82C9AEQ46365540-93D86010-08B9-433C-A19E-929BDC899274Q47651479-BAA4D22B-A82B-474F-8CCE-FBDEB86693C5Q47909554-CC6355C4-B5B3-48EC-ABF3-920A88DB75AAQ52594144-1CC056D6-3755-44EC-8F36-1A2495461E12Q54979981-DFA101E0-20DD-405C-A7ED-785BB9F99FA2
P2860
Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 August 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy.
@en
Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy.
@nl
type
label
Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy.
@en
Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy.
@nl
prefLabel
Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy.
@en
Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy.
@nl
P2093
P2860
P1476
Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy.
@en
P2093
Francisco J Villarreal
George F Schreiner
Katsuyuki Tanabe
Makoto Miyazaki
Miguel A Lanaspa
Norihiko Suzuki
Richard J Johnson
Takahiko Nakagawa
Waichi Sato
Yohei Maeshima
P2860
P304
P356
10.1152/AJPRENAL.00227.2012
P577
2012-08-29T00:00:00Z